Clinical Trial Update: Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma [NA]

View source ↗

Summary

A clinical trial update for a nectin-4–targeted low-molecular-weight PET probe designed for imaging urothelial carcinoma, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Nectin-4 specific LMW PET probe

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Urothelial Carcinoma | NA | Status: RECRUITING